The Swedish Reference Group for Antiviral Therapy (RAV)

RAV is an independent expert group whose members are appointed by the Swedish Society of Medicine (Svenska Läkaresällskapet). RAV was founded in September 1997. The Swedish Medical Products Agency and the Public Health Agency of Sweden have adjunct members, but RAV and the opinions of RAV remain independent of these agencies.

The current chairman is Prof. Johan Westin , Sahlgrenska University Hospital, Gothenburg, Sweden, and the current secretary is Dr Emmi Andersson, the Public Health Agency of Sweden.
The main aim for RAV is to promote rational use of antiviral drugs in Sweden. The group meets four to five times per year.
One important task for RAV has been to initiate the production of guidelines about treatment and management of viral infections such as HIV, hepatitis B and C infection, influenza, CMV and RSV. Several of these guidelines have been produced in collaboration with Swedish Medical Products Agency and the Public Health Agency of Sweden.   

Current recommendations in English:

Prophylaxis and treatment of HIV in pregnancy, 2024: https://www.tandfonline.com/doi/full/10.1080/23744235.2024.2360029

CMV, 2023 : https://www.tandfonline.com/doi/full/10.1080/23744235.2024.2392789

Influenza, 2022: https://www.tandfonline.com/doi/full/10.1080/23744235.2023.2234476

HBV, 2019: https://www.tandfonline.com/doi/full/10.1080/23744235.2019.1675903

BK-virus, 2018: https://www.tandfonline.com/doi/full/10.1080/23744235.2019.1595130